Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, placebo-controlled phase 3 trial
Titel:
Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, placebo-controlled phase 3 trial
Auteur:
Petrylak, Daniel P Vogelzang, Nicholas J Budnik, Nikolay Wiechno, Pawel Jan Sternberg, Cora N Doner, Kevin Bellmunt, Joaquim Burke, John M de Olza, Maria Ochoa Choudhury, Ananya Gschwend, Juergen E Kopyltsov, Evgeny Flechon, Aude Van As, Nicolas Houede, Nadine Barton, Debora Fandi, Abderrahim Jungnelius, Ulf Li, Shaoyi de Wit, Ronald Fizazi, Karim